Journal Title：Journal Of Leukocyte Biology

JLB is a peer-reviewed, academic journal published by the Society for Leukocyte Biology for its members and the community of immunobiologists. The journal publishes papers devoted to the exploration of the cellular and molecular biology of granulocytes, mononuclear phagocytes, lymphocytes, NK cells, and other cells involved in host physiology and defense/resistance against disease. Since all cells in the body can directly or indirectly contribute to the maintenance of the integrity of the organism and restoration of homeostasis through repair, JLB also considers articles involving epithelial, endothelial, fibroblastic, neural, and other somatic cell types participating in host defense. Studies covering pathophysiology, cell development, differentiation and trafficking; fundamental, translational and clinical immunology, inflammation, extracellular mediators and effector molecules; receptors, signal transduction and genes are considered relevant. Research articles and reviews that provide a novel understanding in any of these fields are given priority as well as technical advances related to leukocyte research methods.

JLB 是一份同行評審的學術期刊，由白細胞生物學學會為其會員和免疫生物學家社區出版。該期刊發表的論文致力于探索粒細胞、單核吞噬細胞、淋巴細胞、NK 細胞和其他參與宿主生理和防御/抵抗疾病的細胞的細胞和分子生物學。由于體內所有細胞都可以通過修復直接或間接地促進機體完整性的維持和體內平衡的恢復，JLB 還考慮涉及參與宿主防御的上皮細胞、內皮細胞、成纖維細胞、神經細胞和其他體細胞類型的文章。涉及病理生理學、細胞發育、分化和運輸；基礎、轉化和臨床免疫學、炎癥、細胞外介質和效應分子；受體、信號轉導和基因的研究均被視為相關研究。提供這些領域中任何領域的新見解的研究文章和評論以及與白細胞研究方法相關的技術進步均被優先考慮。

Journal Of Leukocyte Biology創刊于1984年，由John Wiley & Sons Inc.出版商出版，收稿方向涵蓋醫學 - 免疫學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約2月 ，影響因子指數3.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。